Komori
KYORIN Pharmaceutical (4569) · InitiativeSoftened

Distribution Partnership with Nippon Air Liquide for Hand Hygiene Products

First written in FY2017-Q3. 5 of 8 entries say "Advanced", first in FY2017. Latest entry: FY2020-Q3.

8entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017 – FY2018RestatedFY20192017: 420172018: 220182019: 120192020: 12020
Same theme, other companies
Hand hygiene product sales partnership with Nippon Air LiquideA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2020-Q3SoftenedAnnual report

    「The contract period has been changed from “through 31 December 2019 (automatic renewal)” to “through 31 March 2020.”」

    The sales agreement for the hand-hygiene products was changed from an automatic-renewal arrangement to a fixed term ending 31 March 2020.
  2. FY2019RestatedAnnual report

    「Hand-hygiene products | Air Liquide Japan Ltd. | 2017 | Through 31 December 2019 (automatic renewal)」

    The distribution partnership with Air Liquide Japan for hand-hygiene products continues to be listed in the contract list.
  3. FY2018AdvancedAnnual report

    「Sales of the hand-hygiene products launched in the previous fiscal year expanded.」

    The hand-hygiene products launched through the partnership with Air Liquide Japan progressed to higher sales in the following fiscal year.
  4. FY2018-Q3AdvancedAnnual report

    「In addition to growth in Rubista, the principal environmental disinfectant and cleaner, and Milton, a disinfectant for baby bottles, nipples and other equipment, the hand-hygiene products introduced in March 2017 through the distribution partnership with Air Liquide Japan Ltd. contributed to results. Sales of environmental hygiene products, OTC drugs and other products remained above the previous year.」

    The hand-hygiene products launched through the distribution partnership with Air Liquide Japan continued to contribute, and sales of environmental hygiene products, OTC drugs and other products exceeded the previous year.
  5. FY2018-Q2AdvancedAnnual report

    「Sales of the hand-hygiene products introduced in March 2017 through the distribution partnership with Air Liquide Japan Ltd. contributed to results, which remained above the previous year.」

    The launch of hand-hygiene product sales contributed to the healthcare business exceeding the previous year. Revenue in the segment increased 3.3% year on year, and segment profit was ¥75 million.
  6. FY2018-Q1AdvancedAnnual report

    「Sales of the hand-hygiene products introduced through the distribution partnership with Air Liquide Japan Ltd. in January 2017 contributed to results, which remained above the previous year.」

    Following the launch of hand-hygiene product sales, they made a specific contribution to higher revenue in the healthcare business.
  7. FY2017AdvancedAnnual report

    「Kyorin Pharmaceutical Co., Ltd. entered into an agreement with Air Liquide Japan Ltd. in January 2017 for a distribution partnership covering hand-hygiene products in the Japanese market and began selling the products in March of that year.」

    The arrangement progressed from signing the distribution partnership agreement to beginning product sales in March 2017.
  8. FY2017-Q3First statedAnnual report

    「In January 2017, KYORIN Pharmaceutical Co.,Ltd. entered into an agreement with Nippon Air Liquide Co., Ltd. concerning a distribution partnership for a range of hand hygiene products in the Japanese market. The partnership was scheduled to begin around spring 2017.」

    A distribution partnership agreement for hand hygiene products was signed with Nippon Air Liquide, with a planned launch around spring 2017.
Moved together

"Building a Core Business within the Healthcare Business" moved the same way as this thread, in the same document, in 5 of its 8 moves.

555432★123456
  1. ★This thread
  2. 1Building a Core Business within the Healthcare Business5×
  3. 2Expanding the Development Pipeline and Accelerating New Drug Development in 3 Priority Areas5×
  4. 3Expanding the Generic Pharmaceutical Business Primarily through In-House Sales5×
  5. 4Integrating Group Production Operations and Lowering Costs4×
  6. 5Reducing Selling, General and Administrative Expenses3×
  7. 6Decline in Upfront License Fees and Royalty Income2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Distribution Partnership with Nippon Air Liquide for Hand Hygiene Products | KYORIN Pharmaceutical Co.,Ltd. (4569) | Komori